• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NGR肿瘤归巢肽:有效靶向氨肽酶N(CD13)的结构要求

NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting.

作者信息

Graziadio Alessandra, Zanda Matteo, Frau Simona, Fleming Ian N, Musolino Manuele, Dall'Angelo Sergio, Baldassarre Massimiliano, Piras Monica

机构信息

Kosterlitz Centre for Therapeutics and Aberdeen Biomedical Imaging Centre, University of Aberdeen , Aberdeen, AB25 2ZD, Scotland, United Kingdom.

C.N.R. - I.C.R.M. , via Mancinelli 7, 20131 Milan, Italy.

出版信息

Bioconjug Chem. 2016 May 18;27(5):1332-40. doi: 10.1021/acs.bioconjchem.6b00136. Epub 2016 May 2.

DOI:10.1021/acs.bioconjchem.6b00136
PMID:27077642
Abstract

Cyclic CNGRC (cCNGRC) peptides are very important targeting ligands for Aminopeptidase N (APN or CD13), which is overexpressed on the surface of many cancer cells. In this work we have (1) developed an efficient solid-phase synthesis and (2) tested on purified porcine APN and APN-expressing human cells two different classes of cCNGRC peptides: the first carrying a biotin affinity tag or a fluorescent tag attached to the carboxyl Arg-Cys-COOH terminus and the second with the tags attached to the amino H2N-Cys-Asn terminus. Carboxyl-terminus functionalized cCNGRC peptides 3, 6, and 8 showed good affinity for porcine APN and very good capacity to target and be internalized into APN-expressing cells. In contrast, amino-terminus functionalized cCNGRC peptides 4, 5, and 7 displayed significantly decreased affinity and targeting capacity. These results, which are in agreement with the recently reported X-ray structure of a cCNGRC peptide bound to APN showing important stabilizing interactions between the unprotected cCNGRC amino terminus and the APN active site, indicate that the carboxyl and not the amino-terminus of cCNGRC peptides should be used as a "handle" for the attachment of toxic payloads for therapy or isotopically labeled functions for imaging and nuclear medicine.

摘要

环化CNGRC(cCNGRC)肽是氨肽酶N(APN或CD13)非常重要的靶向配体,APN在许多癌细胞表面过度表达。在这项工作中,我们(1)开发了一种高效的固相合成方法,并且(2)在纯化的猪APN和表达APN的人细胞上测试了两类不同的cCNGRC肽:第一类在羧基端的精氨酸-半胱氨酸-COOH末端连接生物素亲和标签或荧光标签,第二类在氨基端的H2N-半胱氨酸-天冬酰胺末端连接标签。羧基末端功能化的cCNGRC肽3、6和8对猪APN表现出良好的亲和力,并且具有很好的靶向和内化进入表达APN细胞的能力。相比之下,氨基末端功能化的cCNGRC肽4、5和7显示出显著降低的亲和力和靶向能力。这些结果与最近报道的与APN结合的cCNGRC肽的X射线结构一致,该结构显示未保护的cCNGRC氨基末端与APN活性位点之间存在重要的稳定相互作用,这表明cCNGRC肽的羧基端而非氨基端应用作连接治疗用有毒负载或用于成像和核医学的同位素标记功能的“手柄”。

相似文献

1
NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting.NGR肿瘤归巢肽:有效靶向氨肽酶N(CD13)的结构要求
Bioconjug Chem. 2016 May 18;27(5):1332-40. doi: 10.1021/acs.bioconjchem.6b00136. Epub 2016 May 2.
2
A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy.基于氨肽酶N的肿瘤细胞运动性和肿瘤归巢治疗的统一机制。
J Biol Chem. 2014 Dec 12;289(50):34520-9. doi: 10.1074/jbc.M114.566802. Epub 2014 Oct 29.
3
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.氨肽酶N是肿瘤归巢肽的受体,也是抑制血管生成的靶点。
Cancer Res. 2000 Feb 1;60(3):722-7.
4
Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using Ga-NODAGA-c(NGR) Peptide.采用 Ga-NODAGA-c(NGR) 肽对实验性肿瘤进行氨肽酶 N(APN/CD13)受体抑制剂治疗效果的分子成像
Biomed Res Int. 2021 Mar 10;2021:6642973. doi: 10.1155/2021/6642973. eCollection 2021.
5
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.环精氨酸肽靶向热敏脂质体的合成及体外评价。
J Control Release. 2010 Apr 19;143(2):265-73. doi: 10.1016/j.jconrel.2009.12.031. Epub 2010 Jan 11.
6
Structure and activity of CPNGRC: a modified CD13/APN peptidic homing motif.CPNGRC 的结构和活性:一种修饰的 CD13/APN 肽同源基序。
Chem Biol Drug Des. 2010 Jun;75(6):551-62. doi: 10.1111/j.1747-0285.2010.00974.x. Epub 2010 Mar 30.
7
68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.68Ga-DOTA-NGR作为一种新型分子探针,用于通过微型正电子发射断层显像仪进行APN阳性肿瘤成像。
Nucl Med Biol. 2014 Mar;41(3):268-75. doi: 10.1016/j.nucmedbio.2013.12.008. Epub 2013 Dec 18.
8
Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.合成及评价 64Cu 标记的单体和二聚型 NGR 肽用于 CD13 受体表达的 MicroPET 成像。
Mol Pharm. 2013 Jan 7;10(1):417-27. doi: 10.1021/mp3005676. Epub 2012 Dec 13.
9
68Ga-labeled cyclic NGR peptide for microPET imaging of CD13 receptor expression.用于CD13受体表达微PET成像的68Ga标记环状NGR肽
Molecules. 2014 Aug 5;19(8):11600-12. doi: 10.3390/molecules190811600.
10
The CNGRC-GG-D(KLAKLAK)2 peptide induces a caspase-independent, Ca2+-dependent death in human leukemic myeloid cells by targeting surface aminopeptidase N/CD13.CNGRC-GG-D(KLAKLAK)2肽通过靶向表面氨肽酶N/CD13在人白血病髓系细胞中诱导一种不依赖半胱天冬酶、依赖Ca2+的死亡。
Oncotarget. 2016 Apr 12;7(15):19445-67. doi: 10.18632/oncotarget.6523.

引用本文的文献

1
A novel aminopeptidase N/CD13 inhibitor selectively targets an endothelial form of CD13 after coupling to proteins.一种新型的氨肽酶 N/CD13 抑制剂在与蛋白偶联后,可选择性地针对 CD13 的一种内皮形式。
Cell Mol Life Sci. 2024 Jan 30;81(1):68. doi: 10.1007/s00018-023-05102-1.
2
Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics.用于癌症治疗的放射性核素和放射性标记肽的进展
Pharmaceutics. 2023 Mar 17;15(3):971. doi: 10.3390/pharmaceutics15030971.
3
Recent advances in surface modification of micro- and nano-scale biomaterials with biological membranes and biomolecules.
微纳尺度生物材料与生物膜和生物分子的表面修饰研究进展
Front Bioeng Biotechnol. 2022 Oct 12;10:972790. doi: 10.3389/fbioe.2022.972790. eCollection 2022.
4
Peptide-based delivery vectors with pre-defined geometrical locks.具有预定义几何锁的肽基递送载体。
RSC Med Chem. 2020 Aug 13;11(11):1303-1313. doi: 10.1039/d0md00229a. eCollection 2020 Nov 18.
5
Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography.正电子发射断层扫描在实验性同源肝细胞癌肿瘤模型中对缺氧和新生血管生成的成像。
Biomed Res Int. 2020 Aug 7;2020:4952372. doi: 10.1155/2020/4952372. eCollection 2020.
6
studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy.用于靶向癌症治疗的配体导向酶前药疗法的CNGRC-CPG2融合蛋白研究。
Oncotarget. 2020 Feb 11;11(6):619-633. doi: 10.18632/oncotarget.27478.
7
Nanocomposites as biomolecules delivery agents in nanomedicine.纳米复合材料作为纳米医学中生物分子的递药载体。
J Nanobiotechnology. 2019 Apr 3;17(1):48. doi: 10.1186/s12951-019-0479-x.
8
Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines.环状肽配体修饰的加速主动靶向纳米药物增强细胞/亚细胞界面穿透并提高抗肿瘤疗效。
Int J Nanomedicine. 2018 Sep 19;13:5537-5559. doi: 10.2147/IJN.S172556. eCollection 2018.
9
Molecular Imaging of Aminopeptidase N in Cancer and Angiogenesis.肿瘤与血管生成中氨肽酶 N 的分子影像学研究
Contrast Media Mol Imaging. 2018 Jun 25;2018:5315172. doi: 10.1155/2018/5315172. eCollection 2018.
10
NGR-peptide-drug conjugates with dual targeting properties.具有双重靶向特性的NGR肽-药物偶联物。
PLoS One. 2017 Jun 2;12(6):e0178632. doi: 10.1371/journal.pone.0178632. eCollection 2017.